These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2081677)

  • 21. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["Torsades de pointe' induced or stimullated by prenylamine. Apropos of 4 cases].
    Normand JP; Kahn JC; Mialet G; Bardet G; Bourdarias JP; Mathivat A
    Ann Cardiol Angeiol (Paris); 1974; 23(6):527-33. PubMed ID: 4460841
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential torsades de pointes triggered by hypokalemia related to olanzapine in a patient with implantable cardioverter-defibrillator.
    Huang G; Fu Q; Xu J
    J Clin Psychopharmacol; 2014 Oct; 34(5):651-2. PubMed ID: 25127223
    [No Abstract]   [Full Text] [Related]  

  • 24. Torsades de pointes associated with astemizole (Hismanal) therapy.
    Goss JE; Ramo BW; Blake K
    Arch Intern Med; 1993 Dec; 153(23):2705. PubMed ID: 8250668
    [No Abstract]   [Full Text] [Related]  

  • 25. Torsade de pointes: a severe and unknown adverse effect in indoramin self-poisoning.
    Nisse P; Soubrier S; Saulnier F; Mathieu-Nolf M
    Int J Cardiol; 2009 Apr; 133(2):e73-5. PubMed ID: 18191476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete heart block and torsade de pointes associated with thioridazine poisoning.
    Hulisz DT; Dasa SL; Black LD; Heiselman DE
    Pharmacotherapy; 1994; 14(2):239-45. PubMed ID: 8197047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
    Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
    Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced long QT syndrome and Torsade de Pointes.
    Chism S; Smith E
    J Ark Med Soc; 2004 Jul; 101(1):24-6. PubMed ID: 15270138
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication.
    Abinader EG; Shahar J
    Cardiology; 1983; 70(1):37-40. PubMed ID: 6850685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torsade de pointes during quinidine and amiodarone therapy].
    Genth S; Darius H; Zotz R; Treese N; Himmrich E; Meyer J
    Med Klin (Munich); 1996 Mar; 91(3):171-3. PubMed ID: 8628204
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.
    Antonelli D; Atar S; Freedberg NA; Rosenfeld T
    Isr Med Assoc J; 2005 Mar; 7(3):163-5. PubMed ID: 15792261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cesium-induced torsades de pointes.
    Pinter A; Dorian P; Newman D
    N Engl J Med; 2002 Jan; 346(5):383-4. PubMed ID: 11821526
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prolonged QT interval and "torsades de pointes" after therapy with prenylamin (Segontin) (author's transl)].
    Burri C; Ajdacic K; Michot F
    Schweiz Rundsch Med Prax; 1981 Apr; 70(16):717-20. PubMed ID: 7335622
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of prenylamine toxicity showing the torsade de pointes phenomenon in sinus rhythm?
    Meanock CI; Noble MI
    Postgrad Med J; 1981 Jun; 57(668):381-4. PubMed ID: 7301686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsade de pointes with prenylamine: do we still need the drug?
    Fraser AG; Ikram S
    Lancet; 1986 Sep; 2(8506):572. PubMed ID: 2875301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.